| Apixaban pharmacokinetics at steady state in hemodialysis patients TA Mavrakanas, CF Samer, SJ Nessim, G Frisch, ML Lipman Journal of the American Society of Nephrology 28 (7), 2241-2248, 2017 | 231 | 2017 |
| The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism T Mavrakanas, H Bounameaux Pharmacology & therapeutics 130 (1), 46-58, 2011 | 136 | 2011 |
| Prevalence of myopia in a sample of Greek students TA Mavracanas, A Mandalos, D Peios, V Golias, K Megalou, ... Acta ophthalmologica Scandinavica 78 (6), 656-659, 2000 | 134 | 2000 |
| Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic … TA Mavrakanas, K Gariani, PY Martin European journal of internal medicine 25 (2), 173-176, 2014 | 101 | 2014 |
| Apixaban versus no anticoagulation in patients undergoing long-term dialysis with incident atrial fibrillation TA Mavrakanas, K Garlo, DM Charytan Clinical Journal of the American Society of Nephrology 15 (8), 1146-1154, 2020 | 87 | 2020 |
| Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case–control and cohort studies K Gariani, T Mavrakanas, C Combescure, A Perrier, C Marti European journal of internal medicine 28, 52-58, 2016 | 69 | 2016 |
| Childhood obesity and elevated blood pressure in a rural population of northern Greece TA Mavrakanas, G Konsoula, I Patsonis, BP Merkouris Rural and Remote Health 9 (2), 1-7, 2009 | 65 | 2009 |
| Cardiovascular complications in chronic dialysis patients TA Mavrakanas, DM Charytan Current opinion in nephrology and hypertension 25 (6), 536-544, 2016 | 56 | 2016 |
| Epidemiology and natural history of the cardiorenal syndromes in a cohort with echocardiography TA Mavrakanas, A Khattak, K Singh, DM Charytan Clinical Journal of the American Society of Nephrology 12 (10), 1624-1633, 2017 | 44 | 2017 |
| Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline L Zeng, M Walsh, GH Guyatt, RAC Siemieniuk, D Collister, M Booth, ... bmj 376, 2022 | 40 | 2022 |
| C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome T Mavrakanas, C Frachebois, A Soualah, F Aloui, I Julier, D Bastide La Presse Médicale 38 (10), 1399-1403, 2009 | 39 | 2009 |
| A prospective study of acute poisonings in a sample of Greek patients T Exiara, TA Mavrakanas, L Papazoglou, D Papazoglou, D Christakidis, ... Central European journal of public health 17 (3), 158-160, 2009 | 39 | 2009 |
| Neutropenia in kidney and liver transplant recipients: risk factors and outcomes TA Mavrakanas, MA Fournier, S Clairoux, JA Amiel, ME Tremblay, ... Clinical transplantation 31 (10), e13058, 2017 | 32 | 2017 |
| The impact of intradialytic pedaling exercise on arterial stiffness: a pilot randomized controlled trial in a hemodialysis population AB Cooke, V Ta, S Iqbal, YH Gomez, T Mavrakanas, P Barré, ... American Journal of Hypertension 31 (4), 458-466, 2018 | 29 | 2018 |
| Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild-moderate CKD TA Mavrakanas, A Khattak, K Singh, DM Charytan BMC nephrology 19, 1-9, 2018 | 27 | 2018 |
| A systematic review of the incidence of arrhythmias in hemodialysis patients undergoing long-term monitoring with implantable loop recorders PR Roberts, K Stromberg, LC Johnson, BM Wiles, TA Mavrakanas, ... Kidney International Reports 6 (1), 56-65, 2021 | 25 | 2021 |
| Duration of dual antiplatelet therapy in patients with CKD and drug-eluting stents: a meta-analysis TA Mavrakanas, YS Chatzizisis, K Gariani, DJ Kereiakes, G Gargiulo, ... Clinical Journal of the American Society of Nephrology 14 (6), 810-822, 2019 | 24 | 2019 |
| Direct oral anticoagulants: efficacy and safety in patient subgroups TA Mavrakanas, C Samer, P Fontana, A Perrier Swiss medical weekly 145 (0506), w14081-w14081, 2015 | 24 | 2015 |
| Association of chronic kidney disease with preserved ejection fraction heart failure is independent of baseline cardiac function TA Mavrakanas, A Khattak, W Wang, K Singh, DM Charytan Kidney and Blood Pressure Research 44 (5), 1247-1258, 2019 | 23 | 2019 |
| Risk of cardiovascular events and mortality among elderly patients with reduced GFR receiving direct oral anticoagulants J Ashley, E McArthur, S Bota, Z Harel, M Battistella, AO Molnar, M Jun, ... American Journal of Kidney Diseases 76 (3), 311-320, 2020 | 20 | 2020 |
Ahsan AlamMcGill University在 mcgill.ca 的电子邮件经过验证
